Our findings demonstrate that MCM7 is upregulated in clinical samples of ccRCC, and its inhibition reduces cellular proliferation and caspase-3/7 activity in RCC cells, confirming its oncogenic potential. The gene discussed is CASP3; the disease is renal cell carcinoma.